bioavailability of oral glutathione vs liposomal New Research Claims to Show Glutathione. But does it really? oral liposomal glutathione bioavailability study

For GHK-Cu wound healing, this means explicitly communicating: GHK-Cu is not FDA-approved as a drug for any indication Human wound-healing evidence is limited to small, non-randomized studies The compounding pharmacy source is not subject to the same oversight as FDA-approved manufacturers Alternative, evidence-based wound-healing options exist (negative pressure wound therapy, growth factor therapies like becaplermin, advanced wound dressings) Monitoring will be required, with associated lab costs Document this conversation in the medical record

What it is claimed to do: Accelerate wound healing and tissue repair Promote new blood vessel formation (angiogenesis) Reduce inflammation Support tendon, ligament, and muscle recovery What the research shows: A study published in the Journal of Physiology and Pharmacology (Sikiric et al., 1997) found that BPC-157 promoted healing in rat models by enhancing granulation tissue formation, angiogenesis, and collagen production

In vitro is a Latin phrase, in glass, that refers to research that is conducted outside of a living organism

Tissue remodeling continues well beyond symptom resolution

Inject at least 2 inches away from the navel, avoiding the midline

While our bodies produce their own supply, various factors can deplete our stores